ORSIRO

[ Chemical and pharmaceutical preparations for medical use, namely, medicated polymer-based preparations, including limus preparations of polyester, polylactic limus preparations and inorganic preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for medical use for improving the biocompatibility of implants, namely, the coating of stents; chemical and pharmaceutical preparations for medical use for improving the healing of implants, namely, medicated stents; chemical products for pharmaceutical use, namely, medicated polymer-based preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for cardiovascular and vascular procedures; drugs for medical use, namely, medicines belonging to the family of limus, namely, derivatives of limus, sirolimus, rapamycin, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus for the treatment of cardiovascular and vascular diseases; medicines for human use for use in cardiovascular and vascular procedures ]

Surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants consisting of artificial materials and surgical instruments; catheters; catheters for percutaneous transluminal coronary angioplasty (PTCA catheters) and catheters for percutaneous translumial angioplasty (PTA catheters), namely, balloon dilatation catheters; medical apparatus and instruments, namely, balloon catheters and stents; stents which can expand by means of balloons; [ self-expanding stents; ] drug-eluting stents [ ; absorbable stents; absorbable drug-eluting stents ]